Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.
Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check14 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedNo new additions were noted, but a significant section of content related to downloading data formats and selecting study fields has been removed.SummaryDifference14%
- Check36 days agoChange DetectedSeveral key government health and information websites have been removed from the monitored list.SummaryDifference0.7%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links to health-related resources and providing enhanced options for downloading study data in various formats.SummaryDifference17%
- Check50 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.